查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1620131

2024 年皮下給藥裝置全球市場報告

Subcutaneous Drug Delivery Devices Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

皮下給藥裝置市場規模預計在未來幾年將強勁成長。到2028年，這一數字將以7.5%的年複合成長率(CAGR)成長至368.9億美元。預測期內的預期成長可歸因於生技藥品和生物相似藥市場的擴張、穿戴式給藥系統的採用增加、個人化醫療的成長、醫療報銷政策的改善以及對居家醫療的日益重視。預計未來的主要趨勢包括數位健康技術的整合、智慧和連網型設備的發展、微創手術的增加、無針注射系統的進步以及人工智慧在設備開發中的興起。

糖尿病和心血管疾病（CVD）盛行率的增加預計將推動皮下給藥裝置市場的擴張。這些疾病增加的主要原因包括人口老化、不良飲食習慣、久坐的生活方式、肥胖、社會經濟差距、壓力、環境因素以及獲得預防性醫療保健的機會有限。皮下給藥裝置廣泛應用於糖尿病管理（注射胰島素和其他藥物來控制血糖）和心血管疾病（注射抗凝血劑和降脂劑等藥物），為治療這些慢性疾病提供了方便和便利。進行管理。例如，英國慈善機構 Diabetes 英國在 2023 年 4 月報告稱，英國目前有 430 萬人患有糖尿病，2020 年至 2022 年間，新診斷病例將增加 148,951 例。此外，英國有超過 240 萬人面臨罹患第 2 型糖尿病的高風險。此外，2024 年 5 月，美國疾病管制與預防中心 (CDC) 透露，2022 年將有 702,880 人死於心臟病，占我死亡人數的五分之一。因此，糖尿病和心血管疾病盛行率的上升正在推動皮下給藥裝置市場的成長。

皮下給藥裝置市場的主要參與企業正在專注於開發微型數位液體流量感測器等先進產品，以提高給藥的安全性和準確性。這些感測器可以精確測量液體流速，對於大容量注射器特別有用。例如，2024年5月，瑞士環境和流量感測器供應商Sensirion AG發布了SLD3x系列感測器平台。該系列包括高精度數位液體流量感測器，具有可自訂的功能，可實現精確流量測量、堵塞檢測、氣泡識別和液體溫度監測。這些微型感測器適用於大規模醫療設備製造，可確保最佳劑量並提高皮下給藥過程中患者的安全性。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球皮下給藥裝置市場：促進因素與限制因素
    • 市場促進因素
    • 市場限制因素
  • 全球皮下給藥裝置市場表現：規模與成長，2018-2023
  • 全球皮下給藥裝置市場預測：規模與成長，2023-2028 年、2033 年

第6章 市場細分

  • 全球皮下給藥裝置市場：依產品類型分類的績效與預測，2018-2023、2023-2028、2033
  • 胰島素筆
  • 筆針
  • 注射筆
  • 自動注射器
  • 嵌入式泵浦
  • 全球皮下給藥裝置市場：按應用、性能和預測，2018-2023、2023-2028、2033
  • 糖尿病
  • 生育力
  • 腫瘤學
  • 全球皮下給藥裝置市場：按最終用戶、性能和預測，2018-2023、2023-2028、2033
  • 醫院和診所
  • 居家醫療
  • 門診手術中心

第 7 章 區域/國家分析

  • 全球皮下給藥裝置市場：按地區、績效及預測，2018-2023年、2023-2028年、2033年
  • 全球皮下給藥裝置市場：依國家、績效及預測，2018-2023年、2023-2028年、2033年

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • 皮下給藥裝置市場：競爭格局
  • 皮下給藥裝置市場：公司簡介
    • Pfizer Inc.
    • Sanofi SA
    • Roche Holdings Inc.
    • Medtronic plc
    • Eli Lilly and Company

第31章 其他大型創新企業

  • Amgen Inc.
  • Novo Nordisk A/S
  • Becton Dickinson and Company
  • West Pharmaceutical Services Inc.
  • Gerresheimer AG
  • Insulet Corporation
  • SHL Medical AG
  • Tandem Diabetes Care Inc.
  • Ypsomed Holding AG
  • Nemera
  • Elcam Medical Ltd.
  • Owen Mumford Ltd.
  • Haselmeier GmbH
  • Sensile Medical AG
  • Enable Injections Inc.

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章 未來展望與潛力分析

第36章附錄

簡介目錄
Product Code: r20878

Subcutaneous drug delivery devices are medical devices designed to administer medications directly into the subcutaneous tissue, which is the layer of fat and connective tissue just beneath the skin. These devices are employed for delivering various drugs, including insulin, hormones, and biologics, offering a convenient and minimally invasive method of administration.

The main types of subcutaneous drug delivery devices include insulin pens, pen needles, injector pens, auto-injectors, and implantable pumps. Insulin pens are handheld devices used for precise and convenient insulin administration in diabetes management, enabling users to easily measure and inject doses. These devices are used in various applications, such as diabetes, fertility, and oncology, and are utilized by different end-users, including hospitals, clinics, homecare settings, and ambulatory surgical centers.

The subcutaneous drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides subcutaneous drug delivery devices market statistics, including subcutaneous drug delivery devices industry global market size, regional shares, competitors with a subcutaneous drug delivery devices market share, detailed subcutaneous drug delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the subcutaneous drug delivery devices industry. This subcutaneous drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The subcutaneous drug delivery devices market size has grown strongly in recent years. It will grow from $25.78 billion in 2023 to $27.66 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth during the historic period can be attributed to the increasing prevalence of chronic diseases, a growing demand for self-administration of drugs, rising rates of diabetes and obesity, patient preference for convenient treatments, and the expanding geriatric population.

The subcutaneous drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $36.89 billion in 2028 at a compound annual growth rate (CAGR) of 7.5%. The growth projected for the forecast period can be attributed to the expansion of the biologics and biosimilars market, increasing adoption of wearable drug delivery systems, the growth of personalized medicine, improvements in healthcare reimbursement policies, and a growing emphasis on home healthcare. Key trends expected include the integration of digital health technologies, the development of smart and connected devices, a rise in minimally invasive procedures, advancements in needle-free injection systems, and the emergence of artificial intelligence in device development.

The growing prevalence of diabetes and cardiovascular diseases (CVD) is expected to drive the expansion of the subcutaneous drug delivery devices market. The rise in these conditions is largely due to aging populations, poor diets, sedentary lifestyles, obesity, socioeconomic disparities, stress, environmental factors, and limited access to preventive healthcare. Subcutaneous drug delivery devices are widely used in diabetes management to administer insulin and other medications for glycemic control, as well as in CVD to deliver drugs like anticoagulants or lipid-lowering agents, offering a convenient and controlled way to manage these chronic diseases. For example, in April 2023, the British Diabetic Association, a UK-based charity, reported that 4.3 million people in the UK are currently living with diabetes, with new diagnoses increasing by 148,951 from 2020-21 to 2021-22. Additionally, over 2.4 million people in the UK are at high risk of developing type 2 diabetes. Furthermore, in May 2024, the Centers for Disease Control and Prevention (CDC) in the U.S. revealed that heart disease caused 702,880 deaths in 2022, accounting for 1 in every 5 deaths. As a result, the rising prevalence of diabetes and cardiovascular diseases is driving the growth of the subcutaneous drug delivery devices market.

Key players in the subcutaneous drug delivery device market are concentrating on developing advanced products such as miniature digital liquid flow sensors to improve the safety and accuracy of drug delivery. These sensors provide precise measurements of liquid flow rates and are especially useful for large-volume injectors. For instance, in May 2024, Sensirion AG, a Switzerland-based provider of environmental and flow sensors, introduced the SLD3x series sensor platform. This series includes highly accurate digital liquid flow sensors with customizable features, enabling precise flow measurement, occlusion detection, air bubble identification, and liquid temperature monitoring. These miniature sensors are suitable for large-scale medical device production, ensuring optimal dosing and enhanced patient safety in subcutaneous drug delivery.

In May 2022, Halozyme Therapeutics Inc., a US-based biopharmaceutical company, acquired Antares Pharma Inc. for $0.960 billion. This acquisition aims to enhance Halozyme's biopharmaceutical capabilities by incorporating Antares' innovative drug delivery technologies and expanding its portfolio. The goal is to improve patient outcomes and accelerate the global development of Halozyme's ENHANZE technology. Antares Pharma Inc., also based in the US, specializes in subcutaneous drug delivery devices.

Major companies operating in the subcutaneous drug delivery devices market are Pfizer Inc., Sanofi S.A., Roche Holdings Inc., Medtronic plc, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Becton Dickinson and Company, West Pharmaceutical Services Inc., Gerresheimer AG, Insulet Corporation, SHL Medical AG, Tandem Diabetes Care Inc., Ypsomed Holding AG, Nemera, Elcam Medical Ltd., Owen Mumford Ltd., Haselmeier GmbH, Sensile Medical AG, Enable Injections Inc., Unilife Corporation, PharmaJet, Oval Medical Technologies Ltd.

North America was the largest region in the subcutaneous drug delivery devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the market going forward. The regions covered in the subcutaneous drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the subcutaneous drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The subcutaneous drug delivery devices market consists of sales of needles, cartridges, and reservoirs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Subcutaneous Drug Delivery Devices Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on subcutaneous drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for subcutaneous drug delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The subcutaneous drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Insulin Pens; Pen Needles; Injector Pens; Auto-Injectors; Implantable Pumps
  • 2) By Application: Diabetes; Fertility; Oncology
  • 3) By End-User: Hospitals And Clinics; Homecare Settings; Ambulatory Surgical Centers
  • Companies Mentioned: Pfizer Inc.; Sanofi S.A.; Roche Holdings Inc.; Medtronic plc; Eli Lilly and Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Subcutaneous Drug Delivery Devices Market Characteristics

3. Subcutaneous Drug Delivery Devices Market Trends And Strategies

4. Subcutaneous Drug Delivery Devices Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Subcutaneous Drug Delivery Devices Market Size and Growth

  • 5.1. Global Subcutaneous Drug Delivery Devices Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Subcutaneous Drug Delivery Devices Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Subcutaneous Drug Delivery Devices Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Subcutaneous Drug Delivery Devices Market Segmentation

  • 6.1. Global Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Insulin Pens
  • Pen Needles
  • Injector Pens
  • Auto-Injectors
  • Implantable Pumps
  • 6.2. Global Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Diabetes
  • Fertility
  • Oncology
  • 6.3. Global Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals And Clinics
  • Homecare Settings
  • Ambulatory Surgical Centers

7. Subcutaneous Drug Delivery Devices Market Regional And Country Analysis

  • 7.1. Global Subcutaneous Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Subcutaneous Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Subcutaneous Drug Delivery Devices Market

  • 8.1. Asia-Pacific Subcutaneous Drug Delivery Devices Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Subcutaneous Drug Delivery Devices Market

  • 9.1. China Subcutaneous Drug Delivery Devices Market Overview
  • 9.2. China Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Subcutaneous Drug Delivery Devices Market

  • 10.1. India Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Subcutaneous Drug Delivery Devices Market

  • 11.1. Japan Subcutaneous Drug Delivery Devices Market Overview
  • 11.2. Japan Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Subcutaneous Drug Delivery Devices Market

  • 12.1. Australia Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Subcutaneous Drug Delivery Devices Market

  • 13.1. Indonesia Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Subcutaneous Drug Delivery Devices Market

  • 14.1. South Korea Subcutaneous Drug Delivery Devices Market Overview
  • 14.2. South Korea Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Subcutaneous Drug Delivery Devices Market

  • 15.1. Western Europe Subcutaneous Drug Delivery Devices Market Overview
  • 15.2. Western Europe Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Subcutaneous Drug Delivery Devices Market

  • 16.1. UK Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Subcutaneous Drug Delivery Devices Market

  • 17.1. Germany Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Subcutaneous Drug Delivery Devices Market

  • 18.1. France Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Subcutaneous Drug Delivery Devices Market

  • 19.1. Italy Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Subcutaneous Drug Delivery Devices Market

  • 20.1. Spain Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Subcutaneous Drug Delivery Devices Market

  • 21.1. Eastern Europe Subcutaneous Drug Delivery Devices Market Overview
  • 21.2. Eastern Europe Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Subcutaneous Drug Delivery Devices Market

  • 22.1. Russia Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Subcutaneous Drug Delivery Devices Market

  • 23.1. North America Subcutaneous Drug Delivery Devices Market Overview
  • 23.2. North America Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Subcutaneous Drug Delivery Devices Market

  • 24.1. USA Subcutaneous Drug Delivery Devices Market Overview
  • 24.2. USA Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Subcutaneous Drug Delivery Devices Market

  • 25.1. Canada Subcutaneous Drug Delivery Devices Market Overview
  • 25.2. Canada Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Subcutaneous Drug Delivery Devices Market

  • 26.1. South America Subcutaneous Drug Delivery Devices Market Overview
  • 26.2. South America Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Subcutaneous Drug Delivery Devices Market

  • 27.1. Brazil Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Subcutaneous Drug Delivery Devices Market

  • 28.1. Middle East Subcutaneous Drug Delivery Devices Market Overview
  • 28.2. Middle East Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Subcutaneous Drug Delivery Devices Market

  • 29.1. Africa Subcutaneous Drug Delivery Devices Market Overview
  • 29.2. Africa Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Subcutaneous Drug Delivery Devices Market Competitive Landscape And Company Profiles

  • 30.1. Subcutaneous Drug Delivery Devices Market Competitive Landscape
  • 30.2. Subcutaneous Drug Delivery Devices Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Sanofi S.A.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Roche Holdings Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Medtronic plc
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Eli Lilly and Company
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Subcutaneous Drug Delivery Devices Market Other Major And Innovative Companies

  • 31.1. Amgen Inc.
  • 31.2. Novo Nordisk A/S
  • 31.3. Becton Dickinson and Company
  • 31.4. West Pharmaceutical Services Inc.
  • 31.5. Gerresheimer AG
  • 31.6. Insulet Corporation
  • 31.7. SHL Medical AG
  • 31.8. Tandem Diabetes Care Inc.
  • 31.9. Ypsomed Holding AG
  • 31.10. Nemera
  • 31.11. Elcam Medical Ltd.
  • 31.12. Owen Mumford Ltd.
  • 31.13. Haselmeier GmbH
  • 31.14. Sensile Medical AG
  • 31.15. Enable Injections Inc.

32. Global Subcutaneous Drug Delivery Devices Market Competitive Benchmarking

33. Global Subcutaneous Drug Delivery Devices Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Subcutaneous Drug Delivery Devices Market

35. Subcutaneous Drug Delivery Devices Market Future Outlook and Potential Analysis

  • 35.1 Subcutaneous Drug Delivery Devices Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Subcutaneous Drug Delivery Devices Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Subcutaneous Drug Delivery Devices Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer